1. Hu, Chao, Ma, Lin, Gao, Shang, Chen, Wan, Tang, Kang-Lai. 2023. PPP1R3A inhibits osteogenesis and negatively regulates intracellular calcium levels in calcific tendinopathy. In iScience, 26, 107784. doi:10.1016/j.isci.2023.107784. https://pubmed.ncbi.nlm.nih.gov/37876608/
2. Nie, Qian, Zhao, Jue, Zhang, Hongcai, Zhang, Delai, Xie, Wen. 2021. WWP2 and PPP1R3A are abnormally regulated in arrhythmia-induced cardiac damage. In 3 Biotech, 11, 185. doi:10.1007/s13205-021-02719-6. https://pubmed.ncbi.nlm.nih.gov/33927976/
3. Cordero, Pablo, Parikh, Victoria N, Chin, Elizabeth T, Cappola, Thomas, Ashley, Euan A. 2019. Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure. In Nature communications, 10, 2760. doi:10.1038/s41467-019-10591-5. https://pubmed.ncbi.nlm.nih.gov/31235787/
4. Alsina, Katherina M, Hulsurkar, Mohit, Brandenburg, Sören, Lehnart, Stephan E, Wehrens, Xander H T. 2019. Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation. In Circulation, 140, 681-693. doi:10.1161/CIRCULATIONAHA.119.039642. https://pubmed.ncbi.nlm.nih.gov/31185731/
5. Delibegovic, Mirela, Armstrong, Christopher G, Dobbie, Lorraine, Smith, Andrew J H, Cohen, Patricia T W. . Disruption of the striated muscle glycogen targeting subunit PPP1R3A of protein phosphatase 1 leads to increased weight gain, fat deposition, and development of insulin resistance. In Diabetes, 52, 596-604. doi:. https://pubmed.ncbi.nlm.nih.gov/12606498/
6. Sánchez-Pozos, Katy, Ortíz-López, María Guadalupe, Peña-Espinoza, Bárbara I, Sanchez-Flores, Alejandro, Menjivar, Marta. 2018. Whole-exome sequencing in maya indigenous families: variant in PPP1R3A is associated with type 2 diabetes. In Molecular genetics and genomics : MGG, 293, 1205-1216. doi:10.1007/s00438-018-1453-2. https://pubmed.ncbi.nlm.nih.gov/29948331/
7. Mammarella, S, Creati, B, Staniscia, T, Quon, M J, Cama, A. . Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity. In Diabetes, obesity & metabolism, 9, 759-61. doi:. https://pubmed.ncbi.nlm.nih.gov/17697067/
8. Savage, David B, Zhai, Lanmin, Ravikumar, Balasubramanian, O'Rahilly, Stephen, DePaoli-Roach, Anna A. . A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. In PLoS medicine, 5, e27. doi:10.1371/journal.pmed.0050027. https://pubmed.ncbi.nlm.nih.gov/18232732/